DiscoverAvalere Essential VoiceRSV Prevention, Part IV: Immunocompromised Populations
RSV Prevention, Part IV: Immunocompromised Populations

RSV Prevention, Part IV: Immunocompromised Populations

Update: 2022-10-31
Share

Description

Tune into the fourth episode in our video series focused on Respiratory Syncytial Virus (RSV) prevention. In this segment, Avalere experts discuss the evolving landscape of RSV preventive products and considerations for both pediatric and adult populations with chronic medical conditions.

Comments 
loading
In Channel
RSV Prevention, Part IV: Immunocompromised Populations

RSV Prevention, Part IV: Immunocompromised Populations

2022-10-3112:22

RSV Prevention, Part III: Older Adult Vaccination

RSV Prevention, Part III: Older Adult Vaccination

2022-10-1913:01

RSV Prevention, Part II: Pediatric Vaccines and Maternal immunization

RSV Prevention, Part II: Pediatric Vaccines and Maternal immunization

2022-10-0509:35

RSV Prevention, Part I: Pediatric Monoclonal Antibodies

RSV Prevention, Part I: Pediatric Monoclonal Antibodies

2022-09-2808:45

NCDs, Part III: Agency Mandates, Decisions, Coverage, and Access

NCDs, Part III: Agency Mandates, Decisions, Coverage, and Access

2022-09-1409:56

NCDs, Part II: Evidence Development to Fulfill CED Requirements

NCDs, Part II: Evidence Development to Fulfill CED Requirements

2022-06-2220:58

NCDs, Part I: Overview of NCDs, CED, and Potential Access Barriers

NCDs, Part I: Overview of NCDs, CED, and Potential Access Barriers

2022-06-1613:29

Exploring the Kidney Care Environment, Part III: Addressing Healthcare Disparities

Exploring the Kidney Care Environment, Part III: Addressing Healthcare Disparities

2022-03-2810:35

Exploring the Kidney Care Environment, Part II: Policy and Payment Trends

Exploring the Kidney Care Environment, Part II: Policy and Payment Trends

2022-03-1010:00

Intro to the Kidney Care Environment: Key Players, Treatment, and Payment Systems

Intro to the Kidney Care Environment: Key Players, Treatment, and Payment Systems

2022-03-0307:30

HIV/AIDS Prevention and Treatment, Part II

HIV/AIDS Prevention and Treatment, Part II

2021-12-0933:02

World AIDS Day: HIV/AIDS Prevention and Treatment

World AIDS Day: HIV/AIDS Prevention and Treatment

2021-12-0118:23

Navigating Distribution and Third-Party Logistics, Part III

Navigating Distribution and Third-Party Logistics, Part III

2021-11-3022:03

Navigating Distribution and Third-Party Logistics, Part II

Navigating Distribution and Third-Party Logistics, Part II

2021-11-1619:42

Medicare Part D, Part V: What's Next for CMMI?

Medicare Part D, Part V: What's Next for CMMI?

2021-10-2209:19

Medicare Part D, Part IV: Budget Neutrality and Congressional Scoring

Medicare Part D, Part IV: Budget Neutrality and Congressional Scoring

2021-10-1512:05

Medicare Part D, Part III: Impact of Policy Changes on Market Access

Medicare Part D, Part III: Impact of Policy Changes on Market Access

2021-10-0708:17

Medicare Part D, Part II: Understanding Plan Decision-Making

Medicare Part D, Part II: Understanding Plan Decision-Making

2021-09-3014:26

Cell and Gene Therapy in Oncology, Part III

Cell and Gene Therapy in Oncology, Part III

2021-09-2911:43

Medicare Part D, Part I: Key Trends and Pressures

Medicare Part D, Part I: Key Trends and Pressures

2021-09-2312:09

loading
Google Play
Download from Google Play
Castbox
Download from App Store
usUnited States
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

RSV Prevention, Part IV: Immunocompromised Populations

RSV Prevention, Part IV: Immunocompromised Populations

Avalere Health